Literature DB >> 26198978

The management of oral epithelial dysplasia: The Liverpool algorithm.

E A Field1, C E McCarthy2, M W Ho3, B P Rajlawat4, D Holt4, S N Rogers5, A Triantafyllou6, J K Field2, R J Shaw7.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26198978     DOI： 10.1016/j.oraloncology.2015.06.015

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  4 in total

Review 1.  Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners.

Authors:  K Staines; H Rogers
Journal:  Br Dent J       Date:  2017-11-03       Impact factor: 1.626

2.  Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology.

Authors:  Hans Prakash Sathasivam; Ralf Kist; Syed Haider; Max Robinson; Philip Sloan; Peter Thomson; Michael Nugent; John Alexander
Journal:  Br J Cancer       Date:  2021-05-10       Impact factor: 7.640

3.  UK consensus recommendations on the management of oral epithelial dysplasia during COVID-19 pandemic outbreaks.

Authors:  Caroline Elizabeth McCarthy; Stefano Fedele; Michael Ho; Richard Shaw
Journal:  Oral Oncol       Date:  2020-11-19       Impact factor: 5.337

4.  SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.

Authors:  Caroline McCarthy; Joseph Sacco; Stefano Fedele; Michael Ho; Stephen Porter; Triantafillos Liloglou; Bill Greenhalf; Max Robinson; Bridget Young; Silvia Cicconi; Seema Chauhan; Binyam Tesfaye; Richard Jackson; Frances Sherratt; Richard Shaw
Journal:  Trials       Date:  2021-07-05       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.